心室辅助装置治疗相关出血与血栓形成
本文综述连续流旋转泵左心室辅助装置(LVAD)治疗中出血与血栓形成的复杂交互机制。文章整合转化研究信息,阐释连续流泵激活凝血系统与血小板促血栓形成、同时降解高分子量血管性血友病因子并触发异常血管生成促出血的双向病理生理,并提出个体化抗血栓监测与抗凝滴定策略以降低未来LVAD受者的出血与血栓事件率。
要点
- 连续流泵激活凝血与血小板促血栓,同时降解高分子量vWF并触发异常血管生成促出血。
- 溶血、高分子量vWF降解、血小板活化与脉动性减弱共同介导消化道出血、装置血栓与卒中。
- 需发展个体化抗血栓监测与抗凝滴定策略以减少LVAD受者出血与血栓事件。
核心结论
- 连续流泵通过激活凝血系统与血小板促血栓、同时降解高分子量vWF并触发异常血管生成促出血,二者共同介导LVAD常见不良事件。
研究设计与样本
- 综述类,整合LVAD患者转化研究信息,未报告具体检索范围与样本量。
主要发现
- 连续流旋转泵在过去十年显著改善晚期收缩性心力衰竭患者生存,但出血与血栓仍是LVAD治疗的致命弱点。
- 溶血、高分子量vWF降解、血小板活化与脉动性减弱等多种血液学异常的净效应尚不明确,其组合介导消化道出血、装置血栓与卒中。
- 连续流泵激活凝血系统与血小板促血栓,同时降解高分子量vWF并触发异常血管生成促出血。
关键数值与推荐
- 提出个体化抗血栓监测与抗凝滴定策略以降低未来LVAD受者的出血与血栓事件率。
临床怎么用
- 临床应认识到连续流LVAD患者出血与血栓风险并存,需兼顾凝血激活与vWF降解双重机制进行抗血栓管理。
- 可探索个体化抗血栓监测与抗凝滴定以平衡出血与血栓风险。
局限性
- 多种血液学异常的净效应尚不明确,相关机制理解仍有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Over the past decade, continuous-flow rotary pumps have dramatically improved survival for patients with advanced systolic heart failure. Bleeding and thrombosis, however, continue to be the Achilles heel of left ventricular assist device (LVAD) therapy. There is a dynamic and complex interaction between the patient and pump. The net effect of a variety of hematologic derangements, such as hemolysis, high-molecular-weight von Willebrand degradation, platelet activation and diminished pulsatility, is poorly understood. A combination of these factors mediates the common adverse events of gastrointestinal bleeding, device thrombosis and stroke. In this review we incorporate information from translational investigations in LVAD patients to understand how continuous-flow pumps activate the coagulation system and platelets predisposing to thrombosis, while, in parallel, degrade high-molecular-weight von Willebrand factor and trigger abnormal angiogenesis predisposing to bleeding. Finally, we propose novel strategies to develop a personalized approach to anti-thrombotic monitoring and titration of anti-coagulants to minimize the bleeding and thrombotic event rates of future LVAD recipients.
引用
- Shah P, Tantry US, Bliden KP, et al. Bleeding and thrombosis associated with ventricular assist device therapy. J Heart Lung Transplant. 2017. PMID: 28579115. doi:10.1016/j.healun.2017.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。